Related Experiment Video

Updated: Jun 1, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
07:17

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex

Published on: August 2, 2021

Regulation of death complexes formation in tumor necrosis factor receptor signaling

Hien Chau1, Christine Mirtsos, Huey-Lan Huang

  • 1Department of Medical Biophysics/Advanced Medical Discovery Institute/The Campbell Family Institute for Breast Cancer Research, University Health Network, and University of Toronto, 620 University Avenue, Toronto, Ontario, Canada.

Experimental Cell Research
|May 31, 2011
PubMed

Insights

Tumor Necrosis Factor-alpha (TNFα) triggers cell death and survival. This study reveals that cFLIP, RelA, RIP1, and TRAF2 proteins prevent caspase-8 and FADD interaction, controlling TNFα-induced cell death.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Tumor Necrosis Factor-alpha (TNFα) signaling regulates critical cellular processes, including apoptosis and survival.
  • Dysregulation of these processes is implicated in inflammatory diseases, cancer, and autoimmune disorders.
  • Understanding the molecular control of TNFα-mediated cell fate is crucial.

Purpose of the Study:

  • To elucidate the molecular mechanisms controlling TNFα-induced cell death and survival.
  • To investigate the formation of TNFα-induced death signaling complexes in various mouse embryonic fibroblast (MEF) models.
  • To identify key regulatory proteins involved in TNFα sensitivity.

Main Methods:

  • Utilized normal diploid mouse embryonic fibroblasts (MEFs) to model physiological TNFα resistance.
  • Analyzed TNFα-induced death signaling complexes in wild-type (WT) and deficient MEFs (cFLIP-, RelA-, TRAF2-, RIP1-deficient) using gel filtration.
  • Assessed TNFα sensitivity in transformed cell lines and the effect of tyrosine kinase inhibitor STI571 on PDGF-B signaling.

Main Results:

  • Detected high molecular weight complexes of caspase-8 and FADD in TNFα-sensitive, deficient MEFs, particularly those lacking cFLIP.
  • Identified an intermediate complex containing RIP1, TRAF2, and caspase-8 in deficient MEFs.
  • Correlated TNFα sensitivity with death-inducing complex formation in transformed cell lines.

Conclusions:

  • Results suggest that cFLIP, RelA, RIP1, and TRAF2 play roles in preventing the interaction of FADD and caspase-8 in WT MEFs.
  • These proteins are involved in regulating TNFα-induced cell death pathways.
  • The findings contribute to understanding the molecular basis of TNFα resistance and sensitivity.

More Related Videos

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay05:52

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay

Published on: May 12, 2023

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...